Latest filing published 26 Oct 2021 for Metacrine, Inc., €694k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -68.6%Entry US$502.80 · Close at T+365 US$158.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
venBio Global Strategic Fund, L.P.: trading record in brief
This profile gathers the share dealings of venBio Global Strategic Fund, L.P. across 2 companies, led by Metacrine, Inc. and Precision Biosciences Inc. The record holds 7 filings, for trades running from 1 April 2019 to 25 October 2021.
On the open market, the record shows 2 purchases worth €3.2M and 2 sales worth €800k. The net balance comes to €2.4M on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2021: no purchases and 2 sales on the market.
The latest filing, published on 26 October 2021, reports an open-market sale of €694k in Metacrine, Inc. The last purchase on record was published on 22 September 2020, which is 2,239 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to venBio Global Strategic Fund, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 540,667 shares@ US$1.490720.9% of flowCommon StockSEC:0001567619-21-018722:1
- 75,035 shares@ US$1.6383100.0% of flowCommon StockSEC:0001567619-21-018722:0
- 230,000 shares@ US$13.0096.0% of flowCommon StockSEC:0000905148-20-001037:0Canonical exit: 17 Dec 2020 (T+90)
- 2,829,123 sharesCommon StockSEC:0000905148-20-001037:1
- 50,000 shares@ US$16.00100.0% of flowCommon StockSEC:0001012975-19-000254:0Canonical exit: 30 Jun 2019 (T+90)
- 3,747,623 sharesCommon StockSEC:0001012975-19-000254:1
- 467,518 sharesCommon StockSEC:0001012975-19-000254:2
7 of 7 declarations
